These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9790306)

  • 1. Analysis of the T-cell receptors utilized for allogeneic HLA-DR recognition: comparison of different responder-cell donors possessing an identical HLA-DR allele.
    Obata F; Tsunoda-Iizuka M
    Scand J Immunol; 1998 Oct; 48(4):364-70. PubMed ID: 9790306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell receptor diversity expressed by CD4+ T cells activated by primary allogeneic HLA-DR stimulation: estimation of the degree of CDR3 diversity.
    Onda K; Kashiwagi N; Obata F
    Scand J Immunol; 1996 May; 43(5):519-24. PubMed ID: 8633209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM; Hicok KC; Goronzy JJ
    J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles.
    Lobashevsky A; Kotb M; Gaber AO
    Transplantation; 1996 Nov; 62(9):1332-40. PubMed ID: 8932281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictions in the repertoire of allospecific T cells. Contribution of the alpha-helical sequence polymorphism of HLA-DR molecules.
    Goronzy JJ; Xie C; Hu W; Lundy SK; Weyand CM
    J Immunol; 1993 Jul; 151(2):825-36. PubMed ID: 8335912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The T-cell receptor V beta 6 gene usage in alloreactive T-cell responses.
    Hu W; Weyand CM; Goronzy JJ
    Hum Immunol; 1995 Jan; 42(1):72-80. PubMed ID: 7751162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic recognition of HLA-DRB1*0406 by T cells with HLA-DRB1*0403: role of amino acid residue 37 on the beta sheet in T cell recognition.
    Kaneko T; Obata F
    Immunobiology; 1996 Aug; 195(3):261-70. PubMed ID: 8877401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes.
    Slager EH; van der Minne CE; Krüse M; Krueger DD; Griffioen M; Osanto S
    J Immunol; 2004 Apr; 172(8):5095-102. PubMed ID: 15067093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition.
    Boitel B; Ermonval M; Panina-Bordignon P; Mariuzza RA; Lanzavecchia A; Acuto O
    J Exp Med; 1992 Mar; 175(3):765-77. PubMed ID: 1371303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antigenic experience on BJ gene segment usage in human CD4+ T cells.
    Walser-Kuntz DR; Weyand CM; Goronzy JJ
    Int Immunol; 1997 Dec; 9(12):1785-92. PubMed ID: 9466306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sharing of four DR-beta sequence motifs between HLA-DRB1*1601 and DRB1*1101 correlates with frequent degenerate T-cell recognition of HA306-320 peptide complexed to these two molecules.
    Zeliszewski D; Dorval I; Golvano JJ; Prevost A; Borras-Cuesta F; Sterkers G
    Scand J Immunol; 1996 Feb; 43(2):146-54. PubMed ID: 8633194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor usage by HLA-DR3-specific T cell clones isolated from a renal allograft.
    Kumagai-Braesch M; Boyle L; van den Elsen P; Kurnick JT
    Transpl Immunol; 1997 Jun; 5(2):129-35. PubMed ID: 9269035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single residue polymorphism at DR beta 37 affects recognition of peptides by T cells.
    Chen YZ; Matsushita S; Nishimura Y
    Hum Immunol; 1997 Apr; 54(1):30-9. PubMed ID: 9154455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides.
    Lombardi G; Sidhu S; Batchelor JR; Lechler RI
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4190-4. PubMed ID: 2657745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.
    Jones CM; Lake RA; Lamb JR; Faith A
    Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein.
    Caccamo N; Barera A; Di Sano C; Meraviglia S; Ivanyi J; Hudecz F; Bosze S; Dieli F; Salerno A
    Clin Exp Immunol; 2003 Aug; 133(2):260-6. PubMed ID: 12869033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific alphabeta+ T cell clones.
    Zanni MP; von Greyerz S; Schnyder B; Wendland T; Pichler WJ
    Int Immunol; 1998 Apr; 10(4):507-15. PubMed ID: 9620607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation.
    Lindstedt R; Monk N; Lombardi G; Lechler R
    J Immunol; 2001 Jan; 166(2):800-8. PubMed ID: 11145653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.